Literature DB >> 16791048

The natural history of vestibular schwannoma.

Sven-Eric Stangerup1, Per Caye-Thomasen, Mirko Tos, Jens Thomsen.   

Abstract

OBJECTIVE: The incidence of vestibular schwannomas (VSs) approaches 20 per million/yr. As treatment may depend on tumor growth, there is a demand of a treatment strategy based on hard data on the growth pattern of these tumors. This article reports growth data registered prospectively in 552 patients. STUDY
DESIGN: Of the 1,818 consecutive patients, diagnosed with VS during the period from 1975 to 2005, 729 patients were allocated to observation by repetitive magnetic resonance imaging. At least two scans had been performed in 552 patients at the time of data analysis. Two hundred thirty patients had a tumor confined to the internal acoustic meatus, whereas 322 patients had a tumor with an extrameatal extension. Growth to extrameatal extension was the definition for growth in intrameatal tumors, whereas a largest diameter change of more than 2 mm was the criteria for growth/shrinkage of extrameatal tumors. The mean observation time was 3.6 years (range, 1-15 yr).
RESULTS: Seventeen percent of the intrameatal tumors grew, whereas significantly more of the extrameatal tumors displayed growth during the period (28.9%). Growth occurred within the first 5 years after diagnosis. No correlation could be demonstrated between tumor growth rate, sex, or age.
CONCLUSION: VS growth occurs within the first 5 years after diagnosis in a limited number of tumors, primarily in tumors with an extrameatal extension. We found no relation between tumor growth and sex or age. These findings justify primary observation of small tumors. A treatment strategy is proposed for this disease, focusing on the patient group allocated to observation.

Entities:  

Mesh:

Year:  2006        PMID: 16791048     DOI: 10.1097/01.mao.0000217356.73463.e7

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  81 in total

1.  Hearing Preservation in Vestibular Schwannoma Surgery.

Authors:  Joe Saliba; Rick A Friedman; Roberto A Cueva
Journal:  J Neurol Surg B Skull Base       Date:  2019-01-10

2.  Systematic Review of Hearing Preservation in Observed Vestibular Schwannoma.

Authors:  Martin Reznitsky; Per Cayé-Thomasen
Journal:  J Neurol Surg B Skull Base       Date:  2019-03-01

3.  The Changing Paradigm for the Surgical Treatment of Large Vestibular Schwannomas.

Authors:  Roy Thomas Daniel; Constantin Tuleasca; Alda Rocca; Mercy George; Etienne Pralong; Luis Schiappacasse; Michele Zeverino; Raphael Maire; Mahmoud Messerer; Marc Levivier
Journal:  J Neurol Surg B Skull Base       Date:  2018-08-23

Review 4.  [Radiosurgery and fractionated stereotactic radiotherapy of vestibular schwannoma].

Authors:  K Hamm; H-U Herold; G Surber; S Rosahl
Journal:  HNO       Date:  2017-05       Impact factor: 1.284

5.  Single Institutional Experience With Observing 564 Vestibular Schwannomas: Factors Associated With Tumor Growth.

Authors:  Jacob B Hunter; David O Francis; Brendan P O'Connell; Edmond K Kabagambe; Marc L Bennett; George B Wanna; Alejandro Rivas; Reid C Thompson; David S Haynes
Journal:  Otol Neurotol       Date:  2016-12       Impact factor: 2.311

6.  Gene expression, signal transduction pathways and functional networks associated with growth of sporadic vestibular schwannomas.

Authors:  Hjalte C R Sass; Rehannah Borup; Mikkel Alanin; Finn Cilius Nielsen; Per Cayé-Thomasen
Journal:  J Neurooncol       Date:  2016-10-17       Impact factor: 4.130

7.  Clinical features of intracranial vestibular schwannomas.

Authors:  Xiang Huang; Jian Xu; Ming Xu; Liang-Fu Zhou; Rong Zhang; Liqin Lang; Qiwu Xu; Ping Zhong; Mingyu Chen; Ying Wang; Zhenyu Zhang
Journal:  Oncol Lett       Date:  2012-10-31       Impact factor: 2.967

8.  Revision Surgery for Vestibular Schwannomas.

Authors:  Kevin A Peng; Brian S Chen; Mark B Lorenz; Gregory P Lekovic; Marc S Schwartz; William H Slattery; Eric P Wilkinson
Journal:  J Neurol Surg B Skull Base       Date:  2018-04-09

9.  Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas.

Authors:  Matthias A Karajannis; Geneviève Legault; Mari Hagiwara; Marc S Ballas; Krysten Brown; Annette O Nusbaum; Tsivia Hochman; Judith D Goldberg; Kevin M Koch; John G Golfinos; J Thomas Roland; Jeffrey C Allen
Journal:  Neuro Oncol       Date:  2012-07-27       Impact factor: 12.300

10.  Follow-up assessment of vestibular schwannomas: volume quantification versus two-dimensional measurements.

Authors:  Rick van de Langenberg; Bert Jan de Bondt; Patty J Nelemans; Brigitta G Baumert; Robert J Stokroos
Journal:  Neuroradiology       Date:  2009-05-06       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.